InsidersTradesSigma
Total declarations
Company
▲ Purchases (11 ops.)
▼ Sales (0 ops.)
Insider track record
CEODisclosed buys
11
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-42.2%
Across 3 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the complete record of transactions filed by Lehr Martin A., Chief Executive Officer. Insider active across 1 company, notably Context Therapeutics Inc.. Cumulatively, 12 reports have been logged. Breakdown: 11 buys · 0 sell. Total volume traded: €207k. History available since 22 October 2021. The latest transaction was filed on 9 June 2025 (Acquisition). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations12 total
100,000 shares@ US$0.700811.6% of flowCommon StockSEC:0001842952-25-000064:0
Ideal exit: 6 Mar 2026 (T+270)
5,823 shares@ US$0.84150.5% of flowCommon StockSEC:0001842952-23-000030:0
Ideal exit: 18 Nov 2023 (T+270)
5,606 shares@ US$0.87420.5% of flowCommon StockSEC:0001842952-23-000020:0
Ideal exit: 10 Nov 2023 (T+270)
5,040 shares@ US$0.97230.5% of flowCommon StockSEC:0001842952-23-000017:0
Ideal exit: 3 Nov 2023 (T+270)
7,027 shares@ US$0.69740.5% of flowCommon StockSEC:0001842952-23-000012:0
Ideal exit: 27 Oct 2023 (T+270)
6,839 shares@ US$0.71660.5% of flowCommon StockSEC:0001842952-23-000008:0
Ideal exit: 20 Oct 2023 (T+270)
6,783 shares@ US$0.73640.5% of flowCommon StockSEC:0001842952-23-000006:0
Ideal exit: 14 Oct 2023 (T+270)
20,000 shares@ US$0.73981.6% of flowCommon StockSEC:0001842952-22-000112:0
Ideal exit: 12 Sept 2023 (T+270)
13,000 shares@ US$1.85112.7% of flowCommon StockSEC:0001842952-22-000081:0
Ideal exit: 16 May 2023 (T+270)
13,000 shares@ US$3.21920.019% mcap4.6% of flowCommon StockSEC:0001842952-21-000029:0
Ideal exit: 12 Sept 2022 (T+270)
52,680 shares@ US$7.140.16% mcap40.1% of flowCommon StockSEC:0001842952-21-000027:0
10,000 shares@ US$5.000.022% mcap5.3% of flowCommon StockSEC:0001179110-21-009609:0
Ideal exit: 19 Jul 2022 (T+270)
12 of 12 declarations
About Lehr Martin A.
Martin A. Lehr is the Chief Executive Officer of Context Therapeutics Inc. He leads the company's operations and oversees strategic initiatives to ensure its growth in the biopharmaceutical sector. His leadership is essential for navigating a dynamic environment.
